Successful management of a lung cancer patient harbouring both EGFR mutation and EML4-ALK fusion gene with disseminated intravascular coagulation

Lung cancer patients harbouring driver oncogene alterations are markedly responsive to molecular target agents, such as epidermal growth factor receptor (EGFR), tyrosine kinase inhibitor (TKI), and echinoderm microtubule-associated protein like 4 – anaplastic lymphoma kinase (EML4-ALK)-TKI. We encou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Respir Med Case Rep
Main Authors: Fujita, Kohei, Naka, Megumi, Ito, Takanori, Kanai, Osamu, Maekawa, Koichi, Nakatani, Koichi, Mio, Tadashi
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2021
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8024693/
https://ncbi.nlm.nih.gov/pubmed/33854939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2021.101393
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados